Cai Jian, Zhang Changshan, Zhang Hui, Zhao Ting, Lv Binging, Gao Chunfang, Wei Dong
Hepatogastroenterology. 2013 Oct;60(127):1805-8.
BACKGROUND/AIMS: We conducted this study to compare open versus laparoscopy-assisted D2 radical gastrectomy in advanced upper gastric cancer.
We reviewed 84 advanced gastric cancer patients who had pancreas-and-spleen preserving D2 lymph node dissection between March 2008 and March 2012. A comparative study was made about the short-term and long-term effect between laparoscopy-assisted D2 radical gastrectomy (LAG) on 41 patients and open D2 radical gastrectomy (OG) on 43 patients.
The clinical characteristics of patients in the two groups were well matched. Operative findings, postoperative recovery, morbidity, pathological findings in the two groups were also similar. The mean operating time was significantly longer for the LAG group (p=0.001); The Estimated blood loss reduced significantly in the LAG group (p=0.010). The mean number of days when body temperature exceeded 37°C and number of days to get out of bed were significantly shorter in the LAG group (p=0.001 and p=0.014 respectively). There were no postoperative deaths in both groups. The postoperative morbidity rate was 14.63% in the LAG group and 23.26% in the OG group with no significant difference (p=0.314). The overall survival rates were 58.5% and 60.5% in the LAG and OG groups, respectively. The estimated mean survival time is 35.768 months in the LAG group and 38.664 months in the OG group, respectively. There was no statistically significant difference in the overall survival rate for patients in both groups.
As for the advanced gastric cancer patient who is suitable for pancreas-and-spleen preserving D2 radical gastrectomy, LAG is a safe and feasible procedure with adequate lymphadenectomy, good curability and survival rate.
背景/目的:我们开展这项研究以比较进展期上部胃癌的开放手术与腹腔镜辅助D2根治性胃切除术。
我们回顾了2008年3月至2012年3月间接受保留胰腺和脾脏的D2淋巴结清扫术的84例进展期胃癌患者。对41例行腹腔镜辅助D2根治性胃切除术(LAG)的患者与43例行开放D2根治性胃切除术(OG)的患者的短期和长期效果进行了对比研究。
两组患者的临床特征匹配良好。两组的手术所见、术后恢复、发病率、病理所见也相似。LAG组的平均手术时间显著更长(p = 0.001);LAG组的估计失血量显著减少(p = 0.010)。LAG组体温超过37℃的平均天数和下床天数显著更短(分别为p = 0.001和p = 0.014)。两组均无术后死亡病例。LAG组的术后发病率为14.63%,OG组为23.26%,差异无统计学意义(p = 0.314)。LAG组和OG组的总生存率分别为58.5%和60.5%。LAG组的估计平均生存时间为35.768个月,OG组为38.664个月。两组患者的总生存率无统计学显著差异。
对于适合保留胰腺和脾脏的D2根治性胃切除术的进展期胃癌患者,LAG是一种安全可行的手术,具有充分的淋巴结清扫、良好的治愈率和生存率。